Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Berthon, Céline, Raffoux, Emmanuel, Thomas, Xavier, Vey, Norbert, Gomez-Roca, Carlos, Yee, Karen, Taussig, David Christopher, Rezai, Keyvan, Roumier, Christophe, Herait, Patrice, Kahatt, Carmen, QuesnLanguage:
english
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(15)00247-1
Date:
March, 2016
File:
PDF, 483 KB
english, 2016